For example, PAX3-FOXO1 was initially identified as a biomarker for alveolar rhabdomyosarcoma (Singh et al., 2022), but was later found to be present during normal muscle differentiation. Here, FOXO1 is linked to alveolar rhabdomyosarcoma.